1. In Vitro Effects of 2-{4-[Methylthio(methylsulfonyl)]phenyl}-3-substitutedthiazolidin-4-ones on the Acetylcholinesterase Activity in Rat Brain and Lymphocytes: Isoform Selectivity, Kinetic Analysis, and Molecular Docking
- Author
-
Mayara Sandrielly Pereira Soares, Wilson Cunico, Daniel Schuch da Silva, Cristina W. Nogueira, João Luis Rheingantz Scaini, Franciele Martini, Bruna da Silveira de Mattos, Anita Avila de Souza, Cesar Emiliano Hoffman da Silva, Karina S. Machado, Ana Paula Pesarico, and Roselia Maria Spanevello
- Subjects
Male ,0301 basic medicine ,Gene isoform ,Aché ,Stereochemistry ,Hippocampus ,Biochemistry ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,0302 clinical medicine ,Catalytic Domain ,Animals ,Humans ,Moiety ,Lymphocytes ,Enzyme kinetics ,Rats, Wistar ,Cholinesterase ,chemistry.chemical_classification ,Molecular Structure ,biology ,General Medicine ,Acetylcholinesterase ,language.human_language ,In vitro ,Isoenzymes ,Molecular Docking Simulation ,Kinetics ,030104 developmental biology ,Enzyme ,chemistry ,language ,biology.protein ,Thiazolidines ,Cholinesterase Inhibitors ,030217 neurology & neurosurgery ,Protein Binding - Abstract
This work evaluated the in vitro effect of thiazolidin-4-ones on the activity of AChE (total and isoforms) isolated from the cerebral cortex, hippocampus, and lymphocytes. Kinetic parameters were evaluated and molecular docking was performed. Our results showed that thiazolidinones derived from 4-(methylthio)benzaldehyde (1) and from 4-(methylsulfonyl)benzaldehyde (2) were capable of inhibiting the AChE activity in vitro. Three compounds, two with a propylpiperidine (1b and 2b) moiety and one with a 3-(diethylamino)propyl (1c) moiety showed IC50 values of 13.81 μM, and 3.13 μM (1b), 55.36 μM and 44.33 μM (1c) for cerebral cortex and hippocampus, respectively, and 3.11 μM for both (2b). Enzyme kinetics revealed that the type of AChE inhibition was mixed. Compound 1b inhibited the G1 and G4 AChE isoforms, while compounds 1c and 2b selectively inhibited the G4 isoform. Molecular docking showed a possible three-dimensional fit into the enzyme. Our findings showed that these thiazolidin-4-ones, especially those containing the propylpiperidine core, have a potential cholinesterase inhibitory activity and can be considered good candidates for future Alzheimer’s therapy.
- Published
- 2019
- Full Text
- View/download PDF